References
Hodi FS, O'Day SJ, McDermott DF (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711–723
Brahmer JR, Tykodi SS, Chow LQ et al (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 366:2455–2465
Fecher LA, Agarwala SS, Hodi FS, Weber JS (2013) Ipilimumab and its toxicities: a multidisciplinary approach. Oncologist 18:733–743
Topalian SL, Hodi FS, Brahmer JR et al (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366:2443–2454
Topalian SL, Sznol M, McDermott DF, et al. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2014.
Hamid O, Robert C, Daud A, et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. The New England Journal of Medicine 2013.
Du GH, Qin XP, Li Q, Zhou YM, Shen XM, Tang GY (2011) The high expression level of programmed death-1 ligand 2 in oral lichen planus and the possible costimulatory effect on human T cells. J Oral Pathol Med 40:525–532
Schubert MM, Correa ME. Oral graft-versus-host disease. Dental clinics of North America 2008;52:79–109, viii-ix.
Deboni AL, Giordani AJ, Lopes NN (2012) Long-term oral effects in patients treated with radiochemotherapy for head and neck cancer. Supportive care in cancer. Off J Multinatl Assoc Support Care Cancer 20:2903–2911
Pekiner FN, Demirel GY, Borahan MO, Ozbayrak S (2012) Evaluation of cytotoxic T-cell activation, chemokine receptors, and adhesion molecules in blood and serum in patients with oral lichen planus. J Oral Pathol Med 41:484–489
Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A (2010) Pathogenesis of oral lichen planus—a review. J Oral Pathol Med 39:729–734
Liu YC, Lerner UH, Teng YT. Cytokine responses against periodontal infection: protective and destructive roles. Periodontology 2000 2010;52:163–206.
Houshmand B, Rafiei A, Hajilooi M (2012) Influence of cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms in periodontitis. Arch Oral Biol 57:1218–1224
Kawai T, Eisen-Lev R, Seki M, Eastcott JW, Wilson ME, Taubman MA (2000) Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol 164:2102–2109
Gildener-Leapman N, Ferris RL, Bauman JE (2013) Promising systemic immunotherapies in head and neck squamous cell carcinoma. Oral Oncol 49:1089–1096
Chambers MS, Toth BB, Martin JW, Fleming TJ, Lemon JC (1995) Oral and dental management of the cancer patient: prevention and treatment of complications. Supportive care in cancer. Off J Multinatl Assoc Support Care in Cancer 3:168–175
Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC (2008) Oral graft-versus-host disease. Oral Dis 14:396–412
Sanchez AR, Sheridan PJ, Rogers RS (2004) Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report. J Periodontol 75:613–619
Furness S, Bryan G, McMillan R, Worthington HV (2013) Interventions for the management of dry mouth: non-pharmacological interventions. Cochrane Database Syst Rev 8, CD009603
Lalla RV, Bowen J (2014) Barasch A, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy, Cancer
Elad S, Or R, Shapira MY et al (2003) CO2 laser in oral graft-versus-host disease: a pilot study. Bone Marrow Transplant 32:1031–1034
Dijkstra PUSM, Pater R, Spijkervet FKL, Roodenburg JLN (2007) Exercise therapy for trismus in head and neck cancer. Oral Oncol 43:389–394
Coracin FL, Pizzigatti Correa ME, Camargo EE et al (2006) Major salivary gland damage in allogeneic hematopoietic progenitor cell transplantation assessed by scintigraphic methods. Bone Marrow Transplant 37:955–959
Conflict of interest
The aforementioned authors have read and approved the manuscript. This manuscript is not under consideration elsewhere. The authors do not have any financial conflicts of interest nor other relationships which may lead to a conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jackson, L.K., Johnson, D.B., Sosman, J.A. et al. Oral health in oncology: impact of immunotherapy. Support Care Cancer 23, 1–3 (2015). https://doi.org/10.1007/s00520-014-2434-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-014-2434-6